3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Stress Disorders, Post-Traumatic
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Obsessive-Compulsive Disorder
1
Interventions
Cyclophosphamide
216
Methotrexate
140
Cytarabine
131
Vincristine
110
fludarabine phosphate
103
Peripheral Blood Stem Cell Transplantation
98
Filgrastim
92
Etoposide
92
Dexamethasone
89
Mycophenolic Acid
71
Doxorubicin
70
Whole-Body Irradiation
67
Mercaptopurine
66
Busulfan
65
Tacrolimus
64
Radiotherapy
63
Cyclosporine
62
Prednisone
55
Daunorubicin
53
pegaspargase
51
Asparaginase
51
Rituximab
48
fludarabine
47
Granulocyte Colony-Stimulating Factor
46
Melphalan
45
Antilymphocyte Serum
43
Clofarabine
42
Calcium Dobesilate
38
Methylprednisolone
36
Leucovorin
35
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Eye Movement Desensitization Reprocessing
×
Clear all
NCT06110702
2024-04-16
MDL
University of Pisa
Phase NA
Completed
287 enrolled